Click here for the results of a “One month of clot prevention after a stent was as effective as a Year-long course for AFIB.”
Research Highlights:
-
A one-month course of dual clot-preventing therapy followed by a single clot-prevention medication for the remainder of the standard 12-month regimen in adults with atrial fibrillation (AFib) who received a coronary stent was as effective as one year of continuous dual therapy for preventing stroke, heart attack and death.
-
Participants treated with the one-month regimen experienced fewer bleeding problems than those in the year-long dual-treatment group.
-
This is the first study to suggest the one-month strategy is as safe and effective as the standard year-long regimen of dual clot-preventing therapy for people with AFib treated with a stent.
-
Note: The study featured in this news release is a research abstract. Abstracts presented at American Heart Association’s scientific meetings are not peer-reviewed, and the findings are considered preliminary until published as a full manuscript in a peer-reviewed scientific journal.
No comments here.